Vesicular Viral Vector Substitute (3VS) - Prototipazione e validazione di un dispositivo nanotecnologico vescicolare per terapia genica alternativa all’uso di vettori virali
Duration:
6 months (2023)
Principal investigator(s):
- Tania Limongi
Project type:
Corporate-funded and donor-funded research
Funding body:
PRIVATI (Fondazione Compagnia di San Paolo)
Project identification number:
116208
PoliTo role:
Sole Contractor
Structures
Keywords
ERC sectors
Sustainable Development Goals
Budget
Total cost: | € 50,000.00 |
---|---|
Total contribution: | € 50,000.00 |
PoliTo total cost: | € 50,000.00 |
PoliTo contribution: | € 50,000.00 |